This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Type IV collagen is a major structural protein component of basement membrane of all metazoan. It contains a large C-terminal globular domain (NC1 domain) by which three chains associate to form triple helical protomers in a chain specific manner. This also plays a major role in the supramolecular assembly of collagen type IV in the extracellular matrix. Tissue specific protomer types of collagen IV exist in mammals, with ?1.?1.?2 protomer being ubiquitous and ?3.?4.?5 protomer in kidney. The long standing interest of our lab in this project is to determine the crystal structures of NC1 domains in hexameric forms as well as their monomeric components to understand the chain specific assembly type IV collagen. These structures will have strong implications in understanding the role of type IV collagen in tissue development, more specifically, kidney. At least two kidney diseases, namely Alport¿¿s syndrome and Goodpasture¿¿s syndrome, are directly linked to type IV collagen. The molecular structures of [?3.?4.?5]2 and ?3 monomer are especially crucial in understanding the molecular basis for the pathogenesis of Goodpasture syndrome. This is an autoimmune disease in which the antibodies specifically target ?3 NC1 domain in the monomer, but not when it is a part of [?3.?4.?5]2 hexamer. We have determined the first crystal structure of NC1 hexamer, [?1.?1.?2]2 using Br-MAD data collected at SSRL. We have also collected data on ?2 and ?3 monomer crystals, whose structures could not be solved by molecular replacement method using the monomer models from the hexamer. Next, we would attempt to solve these structures by MAD using Se or Br as anomalous scatterer. We have also obtained weakly diffracting crystals of [?3.?4.?5]2 NC1 hexamer, which could not be characterized using the in-house source.
No Sub Projects information available for 5P41RR001209-27 7670
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P41RR001209-27 7670
Patents
No Patents information available for 5P41RR001209-27 7670
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P41RR001209-27 7670
Clinical Studies
No Clinical Studies information available for 5P41RR001209-27 7670
News and More
Related News Releases
No news release information available for 5P41RR001209-27 7670
History
No Historical information available for 5P41RR001209-27 7670
Similar Projects
No Similar Projects information available for 5P41RR001209-27 7670